LASA

Lasa Supergenerics Share Price

₹26.34 -1.83 (-6.5%)

28 Dec, 2024 01:59

SIP TrendupStart SIP in LASA

Start SIP

Performance

  • Low
  • ₹25
  • High
  • ₹29
  • 52 Week Low
  • ₹19
  • 52 Week High
  • ₹41
  • Open Price₹29
  • Previous Close₹28
  • Volume105,844

Investment Returns

  • Over 1 Month + 9.75%
  • Over 3 Month -5.42%
  • Over 6 Month + 14.17%
  • Over 1 Year -11.91%
SIP Lightning

Smart Investing Starts Here Start SIP with Lasa Supergenerics for Steady Growth!

Invest Now

Lasa Supergenerics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -5.8
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 132
  • P/B Ratio
  • 1.4
  • Average True Range
  • 1.56
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.57
  • RSI
  • 43.34
  • MFI
  • 67.07

Lasa Supergenerics Financials

Lasa Supergenerics Technicals

EMA & SMA

Current Price
₹26.34
-1.83 (-6.5%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹27.53
  • 50 Day
  • ₹27.05
  • 100 Day
  • ₹26.78
  • 200 Day
  • ₹26.65

Resistance and Support

26.82 Pivot Speed
  • R3 31.58
  • R2 30.15
  • R1 28.25
  • S1 24.92
  • S2 23.49
  • S3 21.59

What's your outlook on Lasa Supergenerics?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics has an operating revenue of Rs. 119.71 Cr. on a trailing 12-month basis. An annual revenue de-growth of -21% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -22% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 10% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Lasa Supergenerics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-13 Quarterly Results
2023-11-10 Quarterly Results

Lasa Supergenerics F&O

Lasa Supergenerics Shareholding Pattern

53.65%
0.01%
34.07%
12.27%

About Lasa Supergenerics

  • NSE Symbol
  • LASA
  • BSE Symbol
  • 540702
  • Chairman & Managing Director
  • Dr. Omkar Pravin Herlekar
  • ISIN
  • INE670X01014

Similar Stocks to Lasa Supergenerics

Lasa Supergenerics FAQs

Lasa Supergenerics share price is ₹26 As on 28 December, 2024 | 01:45

The Market Cap of Lasa Supergenerics is ₹132 Cr As on 28 December, 2024 | 01:45

The P/E ratio of Lasa Supergenerics is -5.8 As on 28 December, 2024 | 01:45

The PB ratio of Lasa Supergenerics is 1.4 As on 28 December, 2024 | 01:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23